HBL - HADASIT BIO-HOLDINGS LTD Financials HBL - Hadasit Bio-Holdings Ltd
Equities
HDST-M
IL0010954050
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.5 ILa | +0.93% |
|
+0.93% | -18.66% |
| Mar. 12 | HBL - Hadasit Bio-Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 11 | CEO of Pakistan's largest bank picked to lead country out of economic crisis | RE |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 54.36 | 40.94 | 64.56 | 36.92 | 14.37 | 7.429 |
| Enterprise Value (EV) 1 | 36.37 | 37.88 | 30.05 | 13 | 1.44 | 0.9693 |
| P/E ratio | -172 x | -1.84 x | 2.06 x | 1.3 x | -0.46 x | -0.25 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 217 x | 1,780 x | - | - | - | - |
| EV / Revenue | 145 x | 1,647 x | - | - | - | - |
| EV / EBITDA | -13 x | -10.8 x | -22.9 x | -6.25 x | -0.53 x | -0.55 x |
| EV / FCF | -12.4 x | 60.1 x | -8.54 x | -7.72 x | -1.23 x | -0.68 x |
| FCF Yield | -8.06% | 1.66% | -11.7% | -12.9% | -81% | -148% |
| Price to Book | 1.59 x | 7.52 x | 1.74 x | 0.56 x | 0.41 x | 1.25 x |
| Nbr of stocks (in thousands) | 11,053 | 11,053 | 11,089 | 11,089 | 11,089 | 11,089 |
| Reference price 2 | 4.918 | 3.704 | 5.822 | 3.330 | 1.296 | 0.6700 |
| Announcement Date | 3/28/19 | 4/30/20 | 3/25/21 | 3/24/22 | 3/28/23 | 3/12/24 |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.25 | 0.023 | - | - | - | - |
| EBITDA 1 | -2.796 | -3.499 | -1.312 | -2.079 | -2.729 | -1.778 |
| EBIT 1 | -3.043 | -3.506 | -1.32 | -2.083 | -2.732 | -1.781 |
| Operating Margin | -1,217.2% | -15,243.48% | - | - | - | - |
| Earnings before Tax (EBT) 1 | -4.128 | -22.3 | 31.22 | 28.36 | -31.21 | -29.19 |
| Net income 1 | -0.316 | -22.3 | 31.21 | 28.36 | -31.21 | -29.19 |
| Net margin | -126.4% | -96,934.78% | - | - | - | - |
| EPS 2 | -0.0286 | -2.017 | 2.820 | 2.558 | -2.815 | -2.632 |
| Free Cash Flow 1 | -2.931 | 0.63 | -3.516 | -1.683 | -1.166 | -1.432 |
| FCF margin | -1,172.45% | 2,739.13% | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/28/19 | 4/30/20 | 3/25/21 | 3/24/22 | 3/28/23 | 3/12/24 |
1ILS in Million2ILS
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 18 | 3.06 | 34.5 | 23.9 | 12.9 | 6.46 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -2.93 | 0.63 | -3.52 | -1.68 | -1.17 | -1.43 |
| ROE (net income / shareholders' equity) | -8.9% | -112% | 147% | 55.2% | -61.9% | -142% |
| ROA (Net income/ Total Assets) | -3.66% | -9.79% | -3.25% | -2.42% | -3.24% | -4.73% |
| Assets 1 | 8.635 | 227.6 | -960.7 | -1,174 | 963 | 616.4 |
| Book Value Per Share 2 | 3.100 | 0.4900 | 3.340 | 5.920 | 3.160 | 0.5400 |
| Cash Flow per Share 2 | 1.490 | 0.1800 | 0.4500 | 0.2500 | 0.0700 | 0.0400 |
| Capex 1 | 0.46 | 0.01 | 0 | 0.01 | - | - |
| Capex / Sales | 185.2% | 21.74% | - | - | - | - |
| Announcement Date | 3/28/19 | 4/30/20 | 3/25/21 | 3/24/22 | 3/28/23 | 3/12/24 |
1ILS in Million2ILS
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -18.66% | 1.62M | |
| +26.37% | 44.96B | |
| -1.01% | 42.65B | |
| +46.00% | 41.85B | |
| -5.31% | 29.04B | |
| +9.34% | 26.08B | |
| -21.69% | 19.03B | |
| +6.23% | 12.75B | |
| +26.99% | 12.06B | |
| -3.38% | 11.75B |
- Stock Market
- Equities
- HDST-M Stock
- Financials HBL - Hadasit Bio-Holdings Ltd
